Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	14.18	2.52	4.1	19.79	9.81	15.73
Cash & Cash Equivalents	14.18	2.52	4.1	19.79	9.81	15.73
Cash Growth	115.19%	-38.67%	-79.28%	101.76%	-37.62%	39.15%
Receivables	0.05	0.06	0	0.03	0.06	2.54
Other Current Assets	0.13	1.16	0.72	0.79	0.94	0.49
Total Current Assets	14.37	3.73	4.82	20.61	10.81	18.76
Property, Plant & Equipment	0.54	0.61	0.99	0.58	0.77	0.47
Other Long-Term Assets	0.09	0.12	0.16	0.19	0.01	0.01
Total Long-Term Assets	0.63	0.74	1.15	0.77	0.78	0.48
Total Assets	15	4.46	5.97	21.38	11.59	19.24
Accounts Payable	2.63	3.23	1.88	0.88	0.74	2.49
Current Debt	0.29	0.28	0.25	0.21	0.19	0
Other Current Liabilities	0.52	0.47	0.4	0.28	0.2	0.15
Total Current Liabilities	3.44	3.98	2.53	1.37	1.14	2.64
Long-Term Debt	0.06	0.28	0.56	0	0.21	0
Total Long-Term Liabilities	0.06	0.28	0.56	0	0.21	0
Total Liabilities	3.5	4.26	3.09	1.37	1.35	2.64
Total Debt	0.35	0.56	0.81	0.21	0.41	0
Debt Growth	-43.18%	-31.07%	280.75%	-47.41%	-	-
Retained Earnings	-184.92	-167.89	-148.33	-130.12	-116.64	-108.87
Comprehensive Income	-0.84	-0.83	-1.25	-1.46	-1.95	-1.86
Shareholders' Equity	11.5	0.2	2.88	20.01	10.24	16.59
Net Cash / Debt	13.83	1.96	3.29	19.58	9.41	15.73
Net Cash / Debt Growth	131.72%	-40.55%	-83.20%	108.19%	-40.20%	39.15%
Net Cash Per Share	5.28	1.41	6.84	77.49	156.57	312.06
Working Capital	10.93	-0.25	2.29	19.24	9.67	16.12
Book Value Per Share	4.40	0.15	6.00	79.19	170.43	329.26

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).